Trials / Completed
CompletedNCT01491451
A Pilot Study of rhBMP-2/ACS With the INTERFIX™ Device for the AnteriorLumbar Interbody Fusion in Patients With Degenerative Disc Disease
A Pilot Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the INTERFIX™ Device for the Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Medtronic Spinal and Biologics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot clinical trial is to evaluate the device design as a method of facilitating spinal fusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | rhBMP-2/ACS/INTERFIX™ | INTERFIX™ device containing recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) and the absorbable collagen sponge (ACS) carrier. |
| DEVICE | Autogenous bone/INTERFIX™ | INTERFIX™ device containing autogenous bone taken from the patient's iliac crest. |
Timeline
- Start date
- 1999-02-01
- Primary completion
- 2003-01-01
- Completion
- 2003-01-01
- First posted
- 2011-12-14
- Last updated
- 2023-05-17
Source: ClinicalTrials.gov record NCT01491451. Inclusion in this directory is not an endorsement.